Gainers
- Anitra AZTR stock moved upwards by 89.1% to $0.53 during Tuesday's pre-market session. The company's market cap stands at $6.5 million.
- Evaxion Biotech EVAX stock increased by 60.83% to $3.86. The company's market cap stands at $24.1 million.
- Achilles Therapeutics ACHL stock rose 22.32% to $1.37. The market value of their outstanding shares is at $58.5 million.
- Invivyd IVVD stock moved upwards by 19.81% to $1.27. The company's market cap stands at $151.9 million.
- Aclarion ACON stock rose 18.79% to $7.9. The market value of their outstanding shares is at $8.0 million.
- Kymera Therapeutics KYMR stock rose 16.91% to $45.0. The market value of their outstanding shares is at $2.9 billion.
Losers
- Universe Pharmaceuticals UPC stock decreased by 28.4% to $0.3 during Tuesday's pre-market session. The company's market cap stands at $2.5 million.
- HCW Biologics HCWB stock fell 19.33% to $0.51. The company's market cap stands at $22.8 million.
- LifeStance Health Gr LFST stock decreased by 12.93% to $7.0. The market value of their outstanding shares is at $2.6 billion.
- Omega Therapeutics OMGA stock decreased by 12.34% to $0.42. The company's market cap stands at $23.2 million.
- GRI Bio GRI shares declined by 12.04% to $0.55. The company's market cap stands at $4.9 million.
- IMAC Hldgs BACK shares decreased by 11.92% to $0.67. The market value of their outstanding shares is at $1.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ACONAclarion Inc
$7.137.22%
AZTRAzitra Inc
$0.28090.86%
BACKIMAC Holdings Inc
$0.6648-12.6%
EVAXEvaxion Biotech AS
$3.2736.1%
GRIGRI Bio Inc
$0.5680-9.81%
HCWBHCW Biologics Inc
$0.5581-12.2%
IVVDInvivyd Inc
$1.2417.0%
KYMRKymera Therapeutics Inc
$38.650.42%
LFSTLifeStance Health Group Inc
$8.04-%
OMGAOmega Therapeutics Inc
$0.1461-69.5%
UPCUniverse Pharmaceuticals Inc
$0.2674-35.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in